Medicine and Dentistry
Abdominal Cancer
49%
Adenocarcinoma
11%
Adverse Event
19%
Bleeding
18%
Capsule Endoscopy
100%
Colon Adenoma
9%
Colonoscopy
18%
Colorectal Carcinoma
13%
Combination Therapy
13%
Computer Assisted Tomography
11%
Crohn's Disease
14%
Diagnosis
50%
Disease
23%
Duodenum
9%
Endoscopy
23%
Enteropathy
12%
Fluorodeoxyglucose
10%
Fluorodeoxyglucose F 18
10%
Gastroesophageal Reflux
35%
Gastrointestinal Bleeding
26%
Gastrointestinal Endoscopy
11%
Hazard Ratio
9%
Helicobacter Infection
12%
Helicobacter Pylori
44%
Infection
11%
Intestine Preparation
23%
Intestine Tumor
12%
Jejunum Ulcer
16%
Lymph Node Metastasis
20%
Macrogol
14%
Matrix Metalloproteinase
9%
Meta-Analysis
9%
Metalloprotease Inhibitor
9%
Metastatic Carcinoma
12%
Neoplasm
30%
Nonsteroid Antiinflammatory Agent
8%
Odds Ratio
24%
Patient with Inflammatory Bowel Disease
9%
Peptic Ulcer Bleeding
14%
Positron Emission Tomography
12%
Positron Emission Tomography-Computed Tomography
11%
Predictive Factor
12%
Prevalence
46%
Pylorus
31%
Recurrent Disease
9%
Reflux Esophagitis
28%
Stomach Acid
12%
Stomach Carcinoma
9%
Surgery
15%
Vasculotropin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
30%
Abdominal Pain
5%
Acetylsalicylic Acid
11%
Adverse Event
19%
Amoxicillin
13%
Antibiotic Resistance
5%
Bleeding
15%
Chronic Diarrhea
5%
Clarithromycin
11%
Clinical Feature
5%
Colitis
9%
Colon Adenoma
9%
Colon Carcinoma
5%
Combination Therapy
13%
Crohn's Disease
9%
Dextran Sulfate
8%
Disease
13%
Disease Activity
5%
Enteropathy
12%
Gastritis
9%
Gastroesophageal Reflux
9%
Gastrointestinal Hemorrhage
17%
Gastrointestinal Symptom
5%
Gelatinase A
6%
Helicobacter Infection
14%
Helicobacter Pylori
55%
Infection
13%
Inflammatory Bowel Disease
11%
Injury
6%
Irritable Colon
6%
Jejunum Ulcer
21%
Lansoprazole
5%
Levofloxacin
7%
Macrogol
9%
Malignant Neoplasm
6%
Messenger RNA
7%
Neoplasm
6%
Non-Steroidal Anti-Inflammatory Drug
13%
Pantoprazole
5%
Peptic Ulcer Bleeding
11%
Prevalence
35%
Proton Pump Inhibitor
7%
Randomized Clinical Trial
5%
Recurrent Disease
7%
Reflux Esophagitis
10%
Retrospective Study
6%
Stomach Acid
8%
Tetracycline
5%
Ulcer
6%
Vasculotropin
7%
Nursing and Health Professions
Abdominal Cancer
13%
Capsule Endoscopy
9%
Colonoscopy
10%
Confidence Interval
7%
Diagnostic Value
8%
Disease Course
5%
Drug Therapy
5%
Enteropathy
7%
Gastroesophageal Reflux
9%
Inflammatory Bowel Disease
5%
Intestine Preparation
11%
Macrogol
10%
Odds Ratio
6%
Patient Compliance
5%
Patient with Inflammatory Bowel Disease
5%
Percutaneous Endoscopic Gastrostomy
7%
Prevalence
25%
Reflux Esophagitis
5%
Surgery
5%
